4 weeks Biotech Stock Roundup: SAGE Up on Declining BIIB’s Offer, CYTK, AKRO Up on Updates Zacks

SAGE and AKRO are up this week on regulatory and pipeline updates.

Biogen (BIIB) · Biotech